AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of July 14, 2026, AEON trades at $0.28 with a market cap of $12.71M and a P/E ratio of -0.09. AEON moved -16.19% today. Year to date, AEON is -70.18%; over the trailing twelve months it is -61.65%. Its 52-week range spans $0.30 to $64.80. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks AEON insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.28 |
| Market Cap | $12.71M |
| P/E Ratio | -0.09 |
| EPS | $-3.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $64.80 |
| 52-Week Low | $0.30 |
| Volume | 41.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.22M |
| Gross Margin | 0.00% |
AEON analyst coverage data. Average price target: $0.00.